Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor

Int J Clin Oncol. 2015 Apr;20(2):249-52. doi: 10.1007/s10147-015-0795-6. Epub 2015 Feb 10.

Author

Hirotaka Iwase¹

Affiliation

¹ Department of Breast and Endocrine Surgery, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan, hiwase@kumamoto-u.ac.jp.

PMID: 25666484
DOI: 10.1007/s10147-015-0795-6

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents, Hormonal / pharmacology
Antineoplastic Agents, Hormonal / therapeutic use*
Aromatase Inhibitors / therapeutic use
Breast Neoplasms / chemistry
Breast Neoplasms / pathology*
Breast Neoplasms / therapy*
Female
Humans
Medroxyprogesterone Acetate / therapeutic use
Neoplasm Metastasis
Receptors, Estrogen / analysis
Selective Estrogen Receptor Modulators / therapeutic use
Signal Transduction / drug effects

Substances

Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Receptors, Estrogen
Selective Estrogen Receptor Modulators
Medroxyprogesterone Acetate